Het project CrossCare 2.0 stimuleert, ondersteunt en versnelt innovaties in de zorg. RheumaFinder maakt gebruik van dit programma om de implementatie van AI-gestuurde beeldanalyse voor vroege detectie van reumatische aandoeningen te optimaliseren binnen ziekenhuizen. Dankzij CrossCare kan RheumaFinder zijn technologie testen, bevragen en doorontwikkelen in samenwerking met zorginstellingen…
RheumaFinder is thrilled to announce a significant achievement for our co-founder, Thomas Van Den Berghe, who successfully defended his PhD at the Ghent University and Ghent University Hospital on Radiomics, Radiogenomics, and Artificial Intelligence in Musculoskeletal Radiology last week. This…
Very happy to be invited yesterday at MEDVIA's and BioWin's sold-out (!) #sfh2024 congress on AI, Data & Digitalisation and explain RheumaFinder's journey in creating clinical impact by early detection and follow-up of rheumatic diseases in everyday medical imaging. Insightful…
Great article featering RheumaFinder and our CEO Nicolaas Fosselle: https://lnkd.in/egtYqcWv on how to get a medtech startup on the rails. Thnx to Voka Oost-Vlaanderen for putting us on the map! Click on the image to read the full article in…
Excellent and insightful article of our CSO Lennart Jans in Artsenkrant discussing the relevant purpose, added value and future of #AI in #radiology. #visionary Artificial intelligence, once considered an abstract concept, has now become an integral part of our daily…